This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Determine when to stay invested versus selling SP 500 in retirement with a simple framework that prioritizes risk control and income needs.
19,195 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Ken Griffin, the Citadel founder once openly skeptical of AI, has pivoted to embracing its potential, telling audienc...
A renewed focus on energy equities is lifting parts of the market today. This piece breaks down what’s driving the mo...
XRP traders are watching a narrow price corridor as Ripple eyes a breakout. With critical support near $1.30 and resi...
A new international ETF pairs overseas blue chips with a covered-call strategy to generate monthly distributions and ...
Honda is shifting strategy, moving toward hybrids while still pursuing a carbon-neutral future. This pivot changes ho...
In this story, meet brothers turned homegrown founders who built an in-house AI agent, then closed a $12 million seed...
Zcash (ZEC) posts a near-90% jump over the last month, bucking broader market weakness. Analysts debate whether this ...
South Korea’s Kospi surged about 8% as investors chased growth stocks amid a debt-fueled rally. A Samsung labor deal ...
Regulators and lenders are accelerating a shift toward scale in mortgage services. The change threatens many smaller ...
XRP has shed roughly 44% over the past year, prompting renewed debate about a rebound. Analysts point to regulatory c...
Ford stock surged 8% on Friday, easily outpacing General Motors and Stellantis as investors focus on Ford Energy and ...